22 results
8-K
EX-99.1
NKTX
Nkarta, Inc.
13 Jun 24
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
4:22pm
expert George Vratsanos, M.D., FACR, is joining its board of directors.
Dr. Vratsanos currently serves as Chief Medical Officer and Head of R&D for Jnana
PRE 14A
NKTX
Nkarta, Inc.
14 Apr 23
Preliminary proxy
5:00pm
for election.
Independent Director Financial Expert Committee Member
2023 PROXY STATEMENT
NKARTA, INC.
CORPORATE GOVERNANCE
Audit Committee
Our Board … Board of Directors has determined that Ms. Patterson is an “audit committee financial expert” as defined by applicable SEC rules.
Committee Members
8-K
EX-10.1
29p77cl
14 Jul 21
Entry into a Material Definitive Agreement
7:07am
DEF 14A
rdtw65
22 Apr 21
Definitive proxy
12:35pm
424B4
2uu7sfq4uavxla8e qgv
10 Jul 20
Prospectus supplement with pricing info
9:35pm
S-1/A
wndfbn8o6alo8fzub
2 Jul 20
IPO registration (amended)
5:17pm
S-1/A
EX-10.1
gdbd3
2 Jul 20
IPO registration (amended)
5:17pm
S-1
EX-10.9
byo6klu l311jnpvo1v7
19 Jun 20
IPO registration
3:24pm
S-1
1tzke03id7b yg
19 Jun 20
IPO registration
3:24pm
S-1
EX-10.10
0dqy22vq
19 Jun 20
IPO registration
3:24pm
DRS/A
xh0smiflebo y0x77j
19 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.9
elgt s0veh
20 Apr 20
Draft registration statement (amended)
12:00am
DRS/A
v4xy dkjw35vz2iotf
20 Apr 20
Draft registration statement (amended)
12:00am